Your Guide to 21 CFR Part 11 Compliance for Life Sciences with a Modern DMS

21 CFR Part 11 governs specified electronic records and signatures used under FDA record requirements. This guide explains its scope and how document management controls can support an assessed compliance program. Software configuration, procedures, training, and intended-use validation remain organizational responsibilities.

Organizations maintaining covered electronic records or signatures under FDA record requirements must assess 21 CFR Part 11, the regulation governing specified electronic records and signatures. Its purpose is to make covered electronic records trustworthy, reliable, and generally equivalent to paper records.

Compliance is not optional, nor is it simple. Failing to meet Part 11 requirements can expose organizations to serious risks, including regulatory enforcement actions (warning letters, audit findings, or even product holds and recalls), compromised data integrity, operational delays, reputational damage, and security breaches such as unauthorized access or data loss. That’s why compliance is not just about technology, it’s about ensuring business continuity, protecting patients, and safeguarding brand trust.

The following guide breaks down the key requirements of 21 CFR Part 11 and explains how a modern DMS supports compliance, so you can focus less on risk management and more on advancing innovation.

Subpart A, General Provisions: Scope & Definitions (§11.1–11.3)

Part 11 applies to covered electronic records maintained under FDA record requirements or submitted to FDA, subject to the regulation and applicable exemptions. Determine which records and signatures are in scope before selecting technical and procedural controls. A modern DMS can support those controls; it does not establish compliance by itself.

With the groundwork established, we can now move from the general provisions to the core of Part 11, how electronic records must be managed, validated, and protected to remain trustworthy.

Subpart B, Electronic Records: Ensuring Trust and Traceability

Once organizations establish whether Part 11 applies to them, the next challenge is ensuring that their electronic records are accurate, secure, and regulator-ready. This is where the bulk of compliance requirements come into play.

System Validation (§11.10)

For covered systems, section 11.10(a) addresses accuracy, reliability, consistent intended performance, and the ability to discern invalid or altered records. Use a justified, documented risk-based validation approach for the actual use. Supplier validation evidence can contribute but does not replace that assessment.

Audit Trails (§11.10)

Section 11.10(e) addresses secure, computer-generated, time-stamped audit trails for operator actions that create, modify, or delete covered electronic records. Verify the configured trail, its retention, and its availability for review. A file version history alone is not necessarily sufficient.

Record Retention (§11.10)

Set retention periods from the applicable record requirements and confirm that records and associated audit information remain protected and retrievable for that period. Test the configured controls rather than relying on a generic FDA or ISO retention label.

Access & Authority Controls (§11.10)

Configure and test access, authority, and training controls so authorized personnel perform the permitted actions. Permissions alone do not establish that a person is qualified for a regulated task.

Operational & Device Checks (§11.10)

Assess required operation sequencing, permitted sources of input, and relevant device checks under section 11.10. Test the configured workflow and input controls against intended use; secure coding alone does not demonstrate compliance.

Document Controls (§11.10)

Control revisions, changes, and distribution of the applicable system documentation, and verify how regulated records are maintained. A DMS can support these activities when configured and operated for the defined process.

Open Systems (§11.30)

For open systems, section 11.30 calls for additional measures such as encryption and appropriate digital-signature standards as necessary to maintain record authenticity, integrity, and confidentiality. Assess the actual system boundary and controls. Electronic signatures have separate requirements.

Subpart C, Electronic Signatures: Security and Accountability

Electronic signatures carry the same legal weight as handwritten ones—but only if they meet strict requirements for security, uniqueness, and traceability. Regulators want assurance that every signature can be tied to the right individual, at the right time, for the right reason.

Signature Manifestation & Linking (§11.50–11.70)

Signed electronic records must show the signer's printed name, signing date and time, and the meaning of the signature. Signatures must be linked to their records so they cannot be excised, copied, or transferred to falsify another record by ordinary means. Verify these properties in the configured process.

Unique Identification & Identity Verification (§11.100)

Each electronic signature is tied to a unique user ID and authentication process. Organizations are responsible for verifying identities before assignment.

Signature Components & Sessions (§11.200)

Non-biometric electronic signatures must use at least two distinct identification components, such as an identification code and password. That combination is not automatically multi-factor authentication. Section 11.200 also sets rules for signing during continuous and non-continuous sessions.

Password & Security Controls (§11.300)

For identification codes and passwords, assess uniqueness, periodic checking or revision, loss management, unauthorized-use safeguards, and appropriate device testing under section 11.300. Confirm the configured platform and organizational procedures cover the applicable controls.

Validated intended use, record controls, and signature controls form part of a compliance assessment. Organizational procedures, training, and applicable record obligations must also be addressed.

Key Takeaway: What’s in It for You?

21 CFR Part 11 compliance isn’t just a regulatory checkbox—it’s a shared responsibility that can be turned into a competitive advantage.

This is where a new-generationQuality Management System (QMS) built on a modern Document Management System (DMS) comes in. Designed to align with FDA expectations and global standards such asISO 13485:2016, such modern solutions help organizations implement the required technical controls while also enabling accountability for policies, training, and procedures. With this approach, companies can reduce compliance risk, streamline operations, and demonstrate to regulators that their records and processes are secure, reliable, and transparent.

By combining a modern DMS with strong internal compliance practices, life sciences companies can:

• Minimize the risk of FDA enforcement actions, audit findings, or recalls.
• Protect data integrity and ensure records are regulator-ready.
• Safeguard intellectual property, patient data, and business-critical information.
• Accelerate innovation by reducing compliance burdens and operational bottlenecks.

AODocs can be evaluated as a technical foundation for controlled records and workflows. Confirm the configured validation evidence, audit trail, signatures, permissions, and retention against intended use. If AI features are used, assess eligible sources, output checks, and change control; approved input documents do not guarantee correct AI output.

Importantly, being “AI-powered” and being “validated” are not incompatible, when AI features are integrated into a compliant DMS, they can support 21 CFR Part 11 requirements rather than undermine them.We explain more in this blog post on why AI agents often fail, and how to fix it. We’ll explore this topic further in a dedicated post.

With the right DMS, compliance shifts from a burden to an enabler of quality, trust, and speed to market.

Learn more

• Get your full 21 CFR Part 11 compliance checklist
• Explore our 21 CFR Part 11 assessment
• Check out AODocs’s Knowledge Base summary
• See for yourself: AODocs Quality Management System
• Discover how MedTech Breakthrough o8t Secured Compliance and Quality